Ocular surface complications in diabetes: The interrelationship between insulin and enkephalin

I Purushothaman, IS Zagon, JW Sassani… - Biochemical …, 2021 - Elsevier
Diabetes is a multi-faceted disorder with increasing prevalence and rising healthcare costs.
The burden of diabetes is increased because of associated complications affecting nearly all …

Blockade of OGFr delays the onset and reduces the severity of diabetic ocular surface complications

IS Zagon, JW Sassani… - Experimental …, 2021 - journals.sagepub.com
The opioid growth factor (OGF)–OGF receptor (OGFr) pathway is present in the ocular
surface and functions to maintain homeostasis of the epithelium. The OGF–OGFr pathway …

[HTML][HTML] Dysregulation of the OGF-OGFr pathway and associated diabetic complications

PJ McLaughlin, JW Sassani… - Journal of diabetes and …, 2021 - ncbi.nlm.nih.gov
Background: Diabetes is a worldwide epidemic with more than 550 million individuals
expected to be diagnosed with the disease by 2030. Complications associated with diabetes …

Dysregulation of the OGF–OGFr pathway correlates with elevated serum OGF and ocular surface complications in the diabetic rat

IS Zagon, JW Sassani… - Experimental …, 2020 - journals.sagepub.com
Diabetes often presents with ocular surface complications including dry eye, keratopathy,
and altered sensitivity, along with systemic disorders. A common theme associated with …

[HTML][HTML] The Yin and Yang of the Opioid Growth Regulatory System: Focus on Diabetes—The Lorenz E. Zimmerman Tribute Lecture

JW Sassani, PJ Mc Laughlin, IS Zagon - Journal of diabetes research, 2016 - hindawi.com
The Opioid Growth Regulatory System consists of opioid growth factor (OGF),[Met 5]-
enkephalin, and its unique receptor (OGFr). OGF inhibits cell division when bound to OGFr …

[HTML][HTML] Ocular surface complications result from dysregulation of the OGF‑OGFr signaling pathway in female diabetic rats

I Purushothaman, IS Zagon… - Experimental and …, 2021 - spandidos-publications.com
Approximately 4.5 million women in the United States exhibit diabetes‑associated ocular
complications. The time course and magnitude of these complications, and their association …

[HTML][HTML] Naltrexone as a novel therapeutic for diabetic corneal complications

PJ McLaughlin, JW Sassani… - Journal of cellular …, 2020 - ncbi.nlm.nih.gov
Diabetes is a widespread autoimmune disorder that affects nearly 10% of the adult
population in the United States. In addition to the primary disease, there are numerous …

[HTML][HTML] Elevated Opioid Growth Factor Alters the Limbus in Type 1 Diabetic Rats

PJ McLaughlin, JW Sassani, D Diaz… - Journal of diabetes and …, 2023 - ncbi.nlm.nih.gov
Ocular surface complications occur in more than 50% of individuals diagnosed with
diabetes. The financial and health-related burden of diabetes is increasing annually …

[HTML][HTML] Sex differences in diabetic ocular surface complications and dysregulation of the OGF-OGFr pathway

IS Zagon, JW Sassani… - Journal of diabetes and …, 2022 - ncbi.nlm.nih.gov
Background: Diabetes is a chronic disorder that affects more than 500 million individuals
worldwide. It is a life-long disease with complications that attack nearly all other systems …

Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)–OGF receptor (OGFr) axis with naltrexone: A review

PJ McLaughlin, JW Sassani, MS Klocek, IS Zagon - Brain research bulletin, 2010 - Elsevier
The opioid growth factor (OGF)–OGF receptors (OGFr) axis plays an important role in the
homeostasis and re-epithelialization of the mammalian cornea. This tonically active growth …